Chronic hepatitis C - genotype 1

Chronic hepatitis C - genotype 1 is a persistent hepatic infection lasting at least six months caused by hepatitis C virus belonging to the genotype 1 viral strain, commonly categorized into subtypes 1a or 1b Affecting the hepatic and vascular systems in infected pediatric and adult populations, it represents the most prevalent HCV genetic variant in North America and globally Pathophysiologically, the hepatotropic viral infection triggers sustained immune-mediated hepatic inflammation and hepat...

Chronic hepatitis C - genotype 1 is a persistent hepatic infection lasting at least six months caused by hepatitis C virus belonging to the genotype 1 viral strain, commonly categorized into subtypes 1a or 1b Pathophysiologically, the hepatotropic viral infection triggers sustained immune-mediated hepatic inflammation and hepatocellular injury, often presenting asymptomatically for years before progressing to progressive fibrosis, cirrhosis, end-stage liver disease, or hepatocellular carcinoma

Chronic hepatitis C - genotype 1 is a persistent hepatic infection lasting at least six months caused by hepatitis C virus belonging to the genotype 1 viral strain, commonly categorized into subtypes 1a or 1b Affecting the hepatic and vascular systems in infected pediatric and adult populations, it represents the most prevalent HCV genetic variant in North America and globally Clinically defined by detectable HCV ribonucleic acid (RNA) and specific genotype 1 sequencing, identification of this g...

Pathophysiologically, the hepatotropic viral infection triggers sustained immune-mediated hepatic inflammation and hepatocellular injury, often presenting asymptomatically for years before progressing to progressive fibrosis, cirrhosis, end-stage liver disease, or hepatocellular carcinoma

Clinically defined by detectable HCV ribonucleic acid (RNA) and specific genotype 1 sequencing, identification of this genetic profile historically directed interferon sensitivity and remains vital for selecting targeted direct-acting antiviral therapy regimens

Clinically defined by detectable HCV ribonucleic acid (RNA) and specific genotype 1 sequencing, identification of this genetic profile historically directed interferon sensitivity and remains vital for selecting targeted direct-acting antiviral therapy regimens